|
CNOT10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.647600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.099700E-02 |
| Normal-vs-Stage2 |
5.058600E-01 |
| Normal-vs-Stage3 |
9.166400E-01 |
| Normal-vs-Stage4 |
1.994800E-01 |
| Stage1-vs-Stage2 |
6.495200E-01 |
| Stage1-vs-Stage3 |
2.393200E-01 |
| Stage1-vs-Stage4 |
1.340170E-02 |
| Stage2-vs-Stage3 |
6.499600E-01 |
| Stage2-vs-Stage4 |
1.626230E-01 |
| Stage3-vs-Stage4 |
3.304000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.462000E-02 |
| Normal-vs-AfricanAmerican |
6.342100E-02 |
| Normal-vs-Asian |
3.055400E-01 |
| Caucasian-vs-AfricanAmerican |
6.128400E-01 |
| Caucasian-vs-Asian |
6.434800E-01 |
| AfricanAmerican-vs-Asian |
7.674000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.621600E-01 |
| Normal-vs-Female |
4.20660000000073E-05 |
| Male-vs-Female |
9.82569999999905E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.805800E-01 |
| Normal-vs-Extreme_Weight |
9.462200E-01 |
| Normal-vs-Obese |
3.307900E-02 |
| Normal-vs-Extreme_Obese |
7.273400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.422600E-01 |
| Normal_Weight-vs-Obese |
3.163400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.453600E-01 |
| Extreme_Weight-vs-Obese |
4.760400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.213400E-01 |
| Obese-vs-Extreme_Obese |
5.300400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.300400E-03 |
| Normal-vs-Age(41-60Yrs) |
3.270400E-02 |
| Normal-vs-Age(61-80Yrs) |
2.077000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.569200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.407700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.061950E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.758700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.320000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.318610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.543800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.024850E-03 |
| Normal-VS-Type2 PRCC |
5.194400E-02 |
| Normal-VS-KIRP CIMP |
2.500200E-02 |
| Normal-VS-Unclassified PRCC |
3.709200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.40380000021889E-07 |
| Type1 PRCC-VS-KIRP CIMP |
6.878300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.062800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.753500E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
5.653700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.350820E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.476800E-01 |
| Normal-vs-N1 |
2.486200E-01 |
| Normal-vs-N2 |
5.620200E-02 |
| N0-vs-N1 |
6.007700E-02 |
| N0-vs-N2 |
4.242000E-01 |
| N1-vs-N2 |
1.394360E-01 |
|
|
